Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of Jan-05-2024

  1. Cassava Sciences

    World Rank (Jan-05-2024)
    8,571
    Market Cap (Jan-05-2024)
    1.001 Billion USD
    World Rank (Jul-30-2023)
    9,406
    Market Cap (Jul-30-2023)
    0.876 Billion USD
    World Rank (Dec-25-2022)
    7,118
    Market Cap (Dec-25-2022)
    1.322 Billion USD
    World Rank (Jan-07-2022)
    6,450
    Market Cap (Jan-07-2022)
    1.92 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -76 Million USD
    Annual Net Income in USD
    -76 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    Cassava Sciences is a clinical stage biopharmaceutical company focused on neuroscience. The headquarters is in USA.
    Company Website
    CASSAVA SCIENCES

  2. Nevro

    World Rank (Jan-05-2024)
    10,534
    Market Cap (Jan-05-2024)
    0.703 Billion USD
    World Rank (Jul-30-2023)
    9,415
    Market Cap (Jul-30-2023)
    0.875 Billion USD
    World Rank (Dec-25-2022)
    6,758
    Market Cap (Dec-25-2022)
    1.424 Billion USD
    World Rank (Jan-07-2022)
    5,144
    Market Cap (Jan-07-2022)
    2.76 Billion USD
    Annual Revenue in USD
    406 Million USD
    Annual Operating Income in USD
    -99 Million USD
    Annual Net Income in USD
    3 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile
    Nevro is a medical device company. It created a disruption by offering a next generation approach called HF10 therapy that provides patients with significant pain relief and no paresthesia. The headquarters is in USA.
    Company Website
    NEVRO CORP

  3. Cadre Holdings Inc.

    World Rank (Jan-05-2024)
    7,779
    Market Cap (Jan-05-2024)
    1.185 Billion USD
    World Rank (Jul-30-2023)
    9,454
    Market Cap (Jul-30-2023)
    0.870 Billion USD
    World Rank (Dec-25-2022)
    9,962
    Market Cap (Dec-25-2022)
    0.751 Billion USD
    World Rank (Jan-07-2022)
    11,258
    Market Cap (Jan-07-2022)
    0.72 Billion USD
    Annual Revenue in USD
    457 Million USD
    Annual Operating Income in USD
    21 Million USD
    Annual Net Income in USD
    6 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Website
    Cadre Holdings, Inc.

  4. Innoviva

    World Rank (Jan-05-2024)
    8,240
    Market Cap (Jan-05-2024)
    1.075 Billion USD
    World Rank (Jul-30-2023)
    9,507
    Market Cap (Jul-30-2023)
    0.861 Billion USD
    World Rank (Dec-25-2022)
    8,769
    Market Cap (Dec-25-2022)
    0.924 Billion USD
    World Rank (Jan-07-2022)
    8,422
    Market Cap (Jan-07-2022)
    1.22 Billion USD
    Annual Revenue in USD
    331 Million USD
    Annual Operating Income in USD
    206 Million USD
    Annual Net Income in USD
    213 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Innoviva is a Pharmaceutical company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited. The headquarters is in USA.
    Company Website
    INNOVIVA INC

  5. BioLife Solutions Inc.

    World Rank (Jan-05-2024)
    10,505
    Market Cap (Jan-05-2024)
    0.707 Billion USD
    World Rank (Jul-30-2023)
    9,534
    Market Cap (Jul-30-2023)
    0.858 Billion USD
    World Rank (Dec-25-2022)
    9,928
    Market Cap (Dec-25-2022)
    0.755 Billion USD
    World Rank (Jan-07-2022)
    8,152
    Market Cap (Jan-07-2022)
    1.28 Billion USD
    Annual Revenue in USD
    161 Million USD
    Annual Operating Income in USD
    -40 Million USD
    Annual Net Income in USD
    -139 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    BioLife Solutions is a supplier of class defining cell and Gene Therapy Bioproduction tools and services company. The headquarters is in USA.
    Facts About Company
    BioLife Solutions company annual revenue was 161 million USD and annual net loss was -139 as on 2019.
    Company Website
    BIOLIFE SOLUTIONS

  6. 23andMe Holding Co.

    World Rank (Jan-05-2024)
    13,988
    Market Cap (Jan-05-2024)
    0.399 Billion USD
    World Rank (Jul-30-2023)
    9,578
    Market Cap (Jul-30-2023)
    0.849 Billion USD
    World Rank (Dec-25-2022)
    8,329
    Market Cap (Dec-25-2022)
    1.007 Billion USD
    World Rank (Jan-07-2022)
    5,045
    Market Cap (Jan-07-2022)
    2.84 Billion USD
    Annual Revenue in USD
    271 Million USD
    Annual Net Income in USD
    -217 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    USA
    Company Profile
    23andMe is the technology to genotype and Biotechnology company. The headquarters is in USA.
    Facts About Company
    23andMe company annual revenue was 299 million USD and annual net loss was -311 as on Mar-2023.
    Company Website
    23ANDME HOLDING CO.

  7. Phathom Pharmaceuticals

    World Rank (Jan-05-2024)
    12,344
    Market Cap (Jan-05-2024)
    0.521 Billion USD
    World Rank (Jul-30-2023)
    9,683
    Market Cap (Jul-30-2023)
    0.835 Billion USD
    World Rank (Dec-25-2022)
    12,820
    Market Cap (Dec-25-2022)
    0.470 Billion USD
    World Rank (Jan-07-2022)
    13,041
    Market Cap (Jan-07-2022)
    0.53 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -172 Million USD
    Annual Net Income in USD
    -197 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Phathom Pharmaceuticals is a Clinical Stage Biopharmaceutical company committed to transforming the treatment landscape and improving the lives of patients suffering from acid related gastrointestinal (GI) disorders. The company annual revenue is approximately 74.5 million USD, total assets is 263.9 million USD and 16 employees as on 2019. The headquarters is in USA.
    Company Website
    PHATHOM PHARMACEUTICALS

  8. Ardelyx

    World Rank (Jan-05-2024)
    6,971
    Market Cap (Jan-05-2024)
    1.428 Billion USD
    World Rank (Jul-30-2023)
    9,735
    Market Cap (Jul-30-2023)
    0.828 Billion USD
    World Rank (Dec-25-2022)
    13,070
    Market Cap (Dec-25-2022)
    0.452 Billion USD
    World Rank (Jan-07-2022)
    22,233
    Market Cap (Jan-07-2022)
    0.11 Billion USD
    Annual Revenue in USD
    52 Million USD
    Annual Operating Income in USD
    -64 Million USD
    Annual Net Income in USD
    -67 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile

    Ardelyx is a Biotechnology company enabled to develop a pipeline of drug candidates designed to better manage complications related to kidney and cardiorenal diseases. The headquarters is in USA.

    Facts About Company

    Ardelyx Annual Total Revenue for year ending Dec-2022 was 52 million USD and and Net loss for year ending Dec-2022 was -67 million USD.

    Ardelyx Annual Total Revenue for year ending Dec-2021 was 10 million USD and and Net loss for year ending Dec-2021 was -158 million USD.

    As on 2022, Ardelyx has 133 employees.

    Company Website
    ARDELYX

  9. Avid Bioservices

    World Rank (Jan-05-2024)
    14,171
    Market Cap (Jan-05-2024)
    0.388 Billion USD
    World Rank (Jul-30-2023)
    9,776
    Market Cap (Jul-30-2023)
    0.820 Billion USD
    World Rank (Dec-25-2022)
    9,233
    Market Cap (Dec-25-2022)
    0.852 Billion USD
    World Rank (Jan-07-2022)
    7,831
    Market Cap (Jan-07-2022)
    1.37 Billion USD
    Annual Revenue in USD
    119 Million USD
    Annual Net Income in USD
    127 Million USD
    Annual Results for Period Ending
    Apr-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Avid Bioservices is a biopharmaceuticals company focused on development and manufacture of derived from mammalian cell. The company annual revenue is 95 million USD and annual net income is 11 million USD for year ending April 2021. The headquarters is in USA.
    Company Website
    AVID BIOSERVICES

  10. REGENXBIO Inc.

    World Rank (Jan-05-2024)
    10,026
    Market Cap (Jan-05-2024)
    0.765 Billion USD
    World Rank (Jul-30-2023)
    9,791
    Market Cap (Jul-30-2023)
    0.818 Billion USD
    World Rank (Dec-25-2022)
    8,565
    Market Cap (Dec-25-2022)
    0.963 Billion USD
    World Rank (Jan-07-2022)
    8,285
    Market Cap (Jan-07-2022)
    1.25 Billion USD
    Annual Revenue in USD
    112 Million USD
    Annual Operating Income in USD
    -262 Million USD
    Annual Net Income in USD
    -280 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    REGENXBIO is a Clinical Stage Biotechnology company. The company currently developing gene therapy product candidates for the treatment of retinal, metabolic and neurodegenerative diseases and provide long lasting effects, potentially significantly altering the course of disease and delivering improved patient outcomes. The headquarters is in USA.
    Company Website
    REGENXBIO INC

Share